OncoPharm
OncoPharm
John Bossaer
ESMO 2022 - NICHE-2 and Codebreak 200
11 minutes Posted Sep 15, 2022 at 7:48 pm.
0:00
11:41
Download MP3
Show notes
ESMO 2022 is wrapped and two studies in particular have caught our eyes:
NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer
CODEBREAK: sotorasib vs. docetaxel